Literature DB >> 9038656

Treating Helicobacter pylori--the best is yet to come?

A Harris1, J J Misiewicz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 9038656      PMCID： PMC1383446          DOI： 10.1136/gut.39.6.781

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  16 in total

1.  The British Society of Gastroenterology spring meeting 20-22 March 1996. Abstracts.

Authors: 
Journal:  Gut       Date:  1996       Impact factor: 23.059

2.  Digestive Disease Week and the 95th Annual Meeting of the American Gastroenterological Association. New Orleans, Louisiana, May 15-18, 1994. Abstracts.

Authors: 
Journal:  Gastroenterology       Date:  1994-04       Impact factor: 22.682

3.  Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection.

Authors:  W de Boer; W Driessen; A Jansz; G Tytgat
Journal:  Lancet       Date:  1995-04-01       Impact factor: 79.321

4.  Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: a double-blind, randomized trial.

Authors:  G D Bell; C M Bate; A T Axon; G Tildesley; G D Kerr; J R Green; C E Emmas; M D Taylor
Journal:  Aliment Pharmacol Ther       Date:  1995-10       Impact factor: 8.171

5.  Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori.

Authors:  P Moayyedi; P Sahay; D S Tompkins; A T Axon
Journal:  Eur J Gastroenterol Hepatol       Date:  1995-09       Impact factor: 2.566

6.  Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance.

Authors:  G D Bell; K Powell; S M Burridge; A Pallecaros; P H Jones; P W Gant; G Harrison; J E Trowell
Journal:  Aliment Pharmacol Ther       Date:  1992-08       Impact factor: 8.171

7.  Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication.

Authors:  E J Kuipers; L Lundell; E C Klinkenberg-Knol; N Havu; H P Festen; B Liedman; C B Lamers; J B Jansen; J Dalenback; P Snel; G F Nelis; S G Meuwissen
Journal:  N Engl J Med       Date:  1996-04-18       Impact factor: 91.245

8.  High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease.

Authors:  N Banatvala; G R Davies; Y Abdi; L Clements; D S Rampton; J M Hardie; R A Feldman
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

9.  Low dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers.

Authors:  B H Jaup; A Norrby
Journal:  Am J Gastroenterol       Date:  1995-06       Impact factor: 10.864

10.  One-week low-dose triple therapy for the eradication of Helicobacter pylori infection.

Authors:  J Labenz; M Stolte; G H Rühl; T Becker; B Tillenburg; M Sollböhmer; G Börsch
Journal:  Eur J Gastroenterol Hepatol       Date:  1995-01       Impact factor: 2.566
View more
  6 in total

1.  Clostridium difficile-associated diarrhoea.

Authors:  N Wight; H Curtis; J Hyde; S P Borriello; Y R Mahida
Journal:  Postgrad Med J       Date:  1998-11       Impact factor: 2.401

Review 2.  Treatment of Helicobacter pylori.

Authors:  A Harris
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

3.  Efficacy of omeprazole and amoxicillin with either clarithromycin or metronidazole on eradication of Helicobacter pylori in Chinese peptic ulcer patients.

Authors:  Wei-Hao Sun; Xi-Long Ou; Da-Zhong Cao; Qian Yu; Ting Yu; Jin-Ming Hu; Feng Zhu; Yun-Liang Sun; Xi-Ling Fu; Han Su
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

4.  Helicobacter pylori eradication with a 7-day low-dose triple therapy in hemodialysis patients.

Authors:  Won-Chul Chang; Young-Il Jo; Hyung-Seok Park; Joon Jegal; Jung-Hwan Park; Jong-Ho Lee; Choon-Jo Jin
Journal:  Clin Exp Nephrol       Date:  2010-07-15       Impact factor: 2.801

Review 5.  Helicobacter pylori: Effect of coexisting diseases and update on treatment regimens.

Authors:  Shen-Shong Chang; Hsiao-Yun Hu
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06

6.  The different pathogeneses of sporadic adenoma and adenocarcinoma in non-ampullary lesions of the proximal and distal duodenum.

Authors:  Ayumi Niwa; Seiya Kuwano; Hiroyuki Tomita; Keita Kimura; Yukiya Orihara; Tomohiro Kanayama; Kei Noguchi; Kenji Hisamatsu; Takayuki Nakashima; Yuichiro Hatano; Akihiro Hirata; Tatsuhiko Miyazaki; Kazuhiro Kaneko; Takuji Tanaka; Akira Hara
Journal:  Oncotarget       Date:  2017-06-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.